Cargando…

Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations

Background: The lifespan of Marfan Syndrome (MFS) patients is shortened, especially in patients without early diagnostics, preventive treatment, and elective surgery. Clinically, MFS diagnosis is mainly dependent on phenotypes, but for children, sporadic cases, or suspicious MFS patients, molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Songchang, Fei, Hongjun, Zhang, Junyun, Chen, Yiyao, Huang, Hefeng, Lu, Daru, Xu, Chenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702824/
https://www.ncbi.nlm.nih.gov/pubmed/34957211
http://dx.doi.org/10.3389/fmolb.2021.749842
_version_ 1784621329400463360
author Chen, Songchang
Fei, Hongjun
Zhang, Junyun
Chen, Yiyao
Huang, Hefeng
Lu, Daru
Xu, Chenming
author_facet Chen, Songchang
Fei, Hongjun
Zhang, Junyun
Chen, Yiyao
Huang, Hefeng
Lu, Daru
Xu, Chenming
author_sort Chen, Songchang
collection PubMed
description Background: The lifespan of Marfan Syndrome (MFS) patients is shortened, especially in patients without early diagnostics, preventive treatment, and elective surgery. Clinically, MFS diagnosis is mainly dependent on phenotypes, but for children, sporadic cases, or suspicious MFS patients, molecular genetic testing, and mainly FBN1 mutation screening, plays a significant role in the diagnosis of MFS. PGT-M gives couples that had a family history of monogenic disorders the opportunity to avoid the occurrence of MFS. Methods: In this study, 11 families with MFS were recruited and complete clinical features were collected. Variants were classified and interpreted through pedigree analysis according to guidelines. Two families chose to undergo PGT-M; 16 blastocysts were biopsied and amplified. Haplotype analysis was performed to deduce the embryo’s genotype by using single nucleotide polymorphisms (SNPs) identified in each sample. Results: We identified 11 potential disease-causing FBN1 variants, six of which are novel. All variants were assessed with prediction tools to assess mutation pathogenicity, population databases to evaluate population allele frequency, literature databases to identify whether the variant had been reported in MFS patients, and multiple sequence alignment to carry out conservative analysis. Finally, nine variants were classified as likely pathogenic/pathogenic variants. Among 11 variants, eight variants were missense, and seven of them were located in the Ca-binding EGF-like motifs, moreover, half of them substituted conserved Cysteine residues. We also identified a splice site variant, a frameshift variant, and a synonymous variant. There are two variants that are de novo variants. PGT-M helped two MFS families give birth to a healthy baby not carrying the FBN1 mutation. Conclusions: In the present study, the FBN1 mutation spectrum was enriched, and may help further elucidate the pathogenesis, benefiting clinical diagnosis and management of MFS. We make use of a reliable PGT-M method for the successful birth of healthy babies to two MFS families.
format Online
Article
Text
id pubmed-8702824
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87028242021-12-25 Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations Chen, Songchang Fei, Hongjun Zhang, Junyun Chen, Yiyao Huang, Hefeng Lu, Daru Xu, Chenming Front Mol Biosci Molecular Biosciences Background: The lifespan of Marfan Syndrome (MFS) patients is shortened, especially in patients without early diagnostics, preventive treatment, and elective surgery. Clinically, MFS diagnosis is mainly dependent on phenotypes, but for children, sporadic cases, or suspicious MFS patients, molecular genetic testing, and mainly FBN1 mutation screening, plays a significant role in the diagnosis of MFS. PGT-M gives couples that had a family history of monogenic disorders the opportunity to avoid the occurrence of MFS. Methods: In this study, 11 families with MFS were recruited and complete clinical features were collected. Variants were classified and interpreted through pedigree analysis according to guidelines. Two families chose to undergo PGT-M; 16 blastocysts were biopsied and amplified. Haplotype analysis was performed to deduce the embryo’s genotype by using single nucleotide polymorphisms (SNPs) identified in each sample. Results: We identified 11 potential disease-causing FBN1 variants, six of which are novel. All variants were assessed with prediction tools to assess mutation pathogenicity, population databases to evaluate population allele frequency, literature databases to identify whether the variant had been reported in MFS patients, and multiple sequence alignment to carry out conservative analysis. Finally, nine variants were classified as likely pathogenic/pathogenic variants. Among 11 variants, eight variants were missense, and seven of them were located in the Ca-binding EGF-like motifs, moreover, half of them substituted conserved Cysteine residues. We also identified a splice site variant, a frameshift variant, and a synonymous variant. There are two variants that are de novo variants. PGT-M helped two MFS families give birth to a healthy baby not carrying the FBN1 mutation. Conclusions: In the present study, the FBN1 mutation spectrum was enriched, and may help further elucidate the pathogenesis, benefiting clinical diagnosis and management of MFS. We make use of a reliable PGT-M method for the successful birth of healthy babies to two MFS families. Frontiers Media S.A. 2021-12-10 /pmc/articles/PMC8702824/ /pubmed/34957211 http://dx.doi.org/10.3389/fmolb.2021.749842 Text en Copyright © 2021 Chen, Fei, Zhang, Chen, Huang, Lu and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Chen, Songchang
Fei, Hongjun
Zhang, Junyun
Chen, Yiyao
Huang, Hefeng
Lu, Daru
Xu, Chenming
Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations
title Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations
title_full Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations
title_fullStr Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations
title_full_unstemmed Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations
title_short Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations
title_sort classification and interpretation for 11 fbn1 variants responsible for marfan syndrome and pre-implantation genetic testing (pgt) for two families successfully blocked transmission of the pathogenic mutations
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702824/
https://www.ncbi.nlm.nih.gov/pubmed/34957211
http://dx.doi.org/10.3389/fmolb.2021.749842
work_keys_str_mv AT chensongchang classificationandinterpretationfor11fbn1variantsresponsibleformarfansyndromeandpreimplantationgenetictestingpgtfortwofamiliessuccessfullyblockedtransmissionofthepathogenicmutations
AT feihongjun classificationandinterpretationfor11fbn1variantsresponsibleformarfansyndromeandpreimplantationgenetictestingpgtfortwofamiliessuccessfullyblockedtransmissionofthepathogenicmutations
AT zhangjunyun classificationandinterpretationfor11fbn1variantsresponsibleformarfansyndromeandpreimplantationgenetictestingpgtfortwofamiliessuccessfullyblockedtransmissionofthepathogenicmutations
AT chenyiyao classificationandinterpretationfor11fbn1variantsresponsibleformarfansyndromeandpreimplantationgenetictestingpgtfortwofamiliessuccessfullyblockedtransmissionofthepathogenicmutations
AT huanghefeng classificationandinterpretationfor11fbn1variantsresponsibleformarfansyndromeandpreimplantationgenetictestingpgtfortwofamiliessuccessfullyblockedtransmissionofthepathogenicmutations
AT ludaru classificationandinterpretationfor11fbn1variantsresponsibleformarfansyndromeandpreimplantationgenetictestingpgtfortwofamiliessuccessfullyblockedtransmissionofthepathogenicmutations
AT xuchenming classificationandinterpretationfor11fbn1variantsresponsibleformarfansyndromeandpreimplantationgenetictestingpgtfortwofamiliessuccessfullyblockedtransmissionofthepathogenicmutations